, Tracking Stock Market Picks
Enter Symbol:
Lifepoint Hospitals, Inc. (LPNT) [hlAlert]

Mkt Outperform
up 147.44 %

Lifepoint Hospitals, Inc. (LPNT) rated Mkt Outperform with price target $42 by Avondale

Posted on: Wednesday,  Aug 18, 2010  12:25 PM ET by Avondale

Avondale rated Mkt Outperform Lifepoint Hospitals, Inc. (NASDAQ: LPNT) on 08/18/2010, when the stock price was $32.48.
Since then, Lifepoint Hospitals, Inc. has gained 147.44% as of 01/11/2016's recent price of $80.37.
If you would have followed this Avondale's recommendation on LPNT, you would have gained 147.44% of your investment in 1972 days.

LifePoint Hospitals, Inc. is engaged in the operation of general, acute care hospitals in non-urban communities. The company's general, acute care hospitals usually provide the range of medical and surgical services commonly available in hospitals in non-urban markets. These hospitals also provide diagnostic and emergency services, as well as outpatient and ancillary services including outpatient surgery, laboratory, radiology, respiratory therapy and physical therapy.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as’s Top Analyst Rankings.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/18/2010 12:25 PM Buy
32.48 42.00
as of 12/31/2010
1 Week down  -6.69 %
1 Month down  -3.81 %
3 Months down  -0.62 %
1 YTD up  7.26 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy